FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089247958> ?p ?o ?g. }

• W3089247958 endingPage "68" @default.
• W3089247958 startingPage "59" @default.
• W3089247958 abstract "Introduction. SARS-CoV-2 infection is a public health emergency and several treatments against COVID-19 are in place while investigated simultaneously. Objective. To update on current pharmacological therapies against COVID-19, and its implications in Latin American countries. Material and Methods. Publications on PubMed and in open access journals regarding pharmacological interventions against SARS-CoV-2 infection were reviewed, followed by analysis of the protocols already in place in Latin American countries. Results. Recent clinical data showed that lopinavir/ritonavir therapy was not effective against severe SARS-CoV-2 infection; however, further trials are underway and will help define the role of this therapy. Remdesivir showed significant efficacy in vitro, and clinical improvement in a report of compassionate-use, but data from controlled trials is not available currently. Tocilizumab plays an important role during cytokine storm, and studies revealed promising results. Chloroquine and hydroxychloroquine showed efficacy in vitro but clinical data are controversial, then further trials are needed to assess their role. Convalescent plasma, tocilizumab, lopinavir/ritonavir, chloroquine, and hydroxychloroquine have been approved by the Infectious Diseases Society of America (IDSA) and the Food and Drug Administration (FDA) in the context of clinical research. Various Latin American countries have already implemented antimicrobial therapy within their local protocols. Conclusions. Promising agents, due to the emergency, are currently in some of the Latin American treatment protocols, although restricted to patients with non-favourable clinical course. Results from controlled clinical trials will be required to define the role of these drugs. Misuse and abuse of drugs can cause drug shortages if supply is not secured, and serious adverse effects might occur." @default.
• W3089247958 created "2020-10-01" @default.
• W3089247958 creator A5006366392 @default.
• W3089247958 creator A5011330992 @default.
• W3089247958 creator A5066759408 @default.
• W3089247958 creator A5071519865 @default.
• W3089247958 creator A5088736425 @default.
• W3089247958 date "2020-01-30" @default.
• W3089247958 modified "2023-10-18" @default.
• W3089247958 title "Current Pharmacological Therapy against COVID-19: A Latin American Perspective" @default.
• W3089247958 cites W2057439500 @default.
• W3089247958 cites W2111376288 @default.
• W3089247958 cites W2169492821 @default.
• W3089247958 cites W3000413850 @default.
• W3089247958 cites W3004709581 @default.
• W3089247958 cites W3005212621 @default.
• W3089247958 cites W3006564542 @default.
• W3089247958 cites W3008131087 @default.
• W3089247958 cites W3008763357 @default.
• W3089247958 cites W3009912996 @default.
• W3089247958 cites W3010673910 @default.
• W3089247958 cites W3011379523 @default.
• W3089247958 cites W3012310845 @default.
• W3089247958 cites W3012379316 @default.
• W3089247958 cites W3012421327 @default.
• W3089247958 cites W3013369257 @default.
• W3089247958 cites W3013742505 @default.
• W3089247958 cites W3014599272 @default.
• W3089247958 cites W3014962324 @default.
• W3089247958 cites W3015490759 @default.
• W3089247958 doi "https://doi.org/10.34141/ljcs2640133" @default.
• W3089247958 hasPublicationYear "2020" @default.
• W3089247958 type Work @default.
• W3089247958 sameAs 3089247958 @default.
• W3089247958 citedByCount "3" @default.
• W3089247958 countsByYear W30892479582020 @default.
• W3089247958 countsByYear W30892479582021 @default.
• W3089247958 crossrefType "journal-article" @default.
• W3089247958 hasAuthorship W3089247958A5006366392 @default.
• W3089247958 hasAuthorship W3089247958A5011330992 @default.
• W3089247958 hasAuthorship W3089247958A5066759408 @default.
• W3089247958 hasAuthorship W3089247958A5071519865 @default.
• W3089247958 hasAuthorship W3089247958A5088736425 @default.
• W3089247958 hasBestOaLocation W30892479581 @default.
• W3089247958 hasConcept C126322002 @default.
• W3089247958 hasConcept C142462285 @default.
• W3089247958 hasConcept C151730666 @default.
• W3089247958 hasConcept C177713679 @default.
• W3089247958 hasConcept C2777178219 @default.
• W3089247958 hasConcept C2777182164 @default.
• W3089247958 hasConcept C2779123688 @default.
• W3089247958 hasConcept C2779134260 @default.
• W3089247958 hasConcept C2779298103 @default.
• W3089247958 hasConcept C2779343474 @default.
• W3089247958 hasConcept C2993143319 @default.
• W3089247958 hasConcept C3008058167 @default.
• W3089247958 hasConcept C3013748606 @default.
• W3089247958 hasConcept C512399662 @default.
• W3089247958 hasConcept C524204448 @default.
• W3089247958 hasConcept C535046627 @default.
• W3089247958 hasConcept C71924100 @default.
• W3089247958 hasConcept C86803240 @default.
• W3089247958 hasConceptScore W3089247958C126322002 @default.
• W3089247958 hasConceptScore W3089247958C142462285 @default.
• W3089247958 hasConceptScore W3089247958C151730666 @default.
• W3089247958 hasConceptScore W3089247958C177713679 @default.
• W3089247958 hasConceptScore W3089247958C2777178219 @default.
• W3089247958 hasConceptScore W3089247958C2777182164 @default.
• W3089247958 hasConceptScore W3089247958C2779123688 @default.
• W3089247958 hasConceptScore W3089247958C2779134260 @default.
• W3089247958 hasConceptScore W3089247958C2779298103 @default.
• W3089247958 hasConceptScore W3089247958C2779343474 @default.
• W3089247958 hasConceptScore W3089247958C2993143319 @default.
• W3089247958 hasConceptScore W3089247958C3008058167 @default.
• W3089247958 hasConceptScore W3089247958C3013748606 @default.
• W3089247958 hasConceptScore W3089247958C512399662 @default.
• W3089247958 hasConceptScore W3089247958C524204448 @default.
• W3089247958 hasConceptScore W3089247958C535046627 @default.
• W3089247958 hasConceptScore W3089247958C71924100 @default.
• W3089247958 hasConceptScore W3089247958C86803240 @default.
• W3089247958 hasIssue "2" @default.
• W3089247958 hasLocation W30892479581 @default.
• W3089247958 hasOpenAccess W3089247958 @default.
• W3089247958 hasPrimaryLocation W30892479581 @default.
• W3089247958 hasRelatedWork W3016321432 @default.
• W3089247958 hasRelatedWork W3017796721 @default.
• W3089247958 hasRelatedWork W3043241379 @default.
• W3089247958 hasRelatedWork W3081494414 @default.
• W3089247958 hasRelatedWork W3089247958 @default.
• W3089247958 hasRelatedWork W3092755260 @default.
• W3089247958 hasRelatedWork W3093044201 @default.
• W3089247958 hasRelatedWork W3212119853 @default.
• W3089247958 hasRelatedWork W4213421624 @default.
• W3089247958 hasRelatedWork W4317493065 @default.
• W3089247958 hasVolume "2" @default.
• W3089247958 isParatext "false" @default.
• W3089247958 isRetracted "false" @default.
• W3089247958 magId "3089247958" @default.

• next